Leukemic cell lysis pneumopathy, also referred to as acute lysis pneumopathy, refers to an acute respiratory failure that can occur in patients with leukemia after the initiation of chemotherapy, particularly in those with hyperleukocytosis. On imaging, it manifests with features of acute respiratory distress syndrome (ARDS).
On this page:
Epidemiology
It is commonly seen in those patients with high leukocytes count, over leukocyte counts, 200,000/mL 2,4,
Clinical presentation
It presents an acute onset of respiratory failure usually seen within 48 hours from the start of chemotherapy 4. Associated fevers and hemoptysis have been described 4.
Radiographic features
This pneumopathy presents with imaging features of acute respiratory distress syndrome (ARDS) and diffuse alveolar damage 1-2,4, including extensive areas of pulmonary consolidation 2.
Treatment and complications
Life-supportive measures, with these patients usually admitted to ICU. Steroids, although controversial, are commonly used.
Unable to process the form. Check for errors and try again.